Day: May 3, 2023

OP Corporate Bank plcInterim Report 1 January–31 March 2023Stock Exchange Release 3 May 2023 at 9.00am EEST OP Corporate Bank plc’s Interim Report 1 January–31 March 2023OP Corporate Bank plc’s operating profit (earnings before tax) increased to EUR 81 million (–17). Net interest income increased by 35% to EUR 127 million (94). Investment income increased by EUR 24 million to EUR 31 million (7). Net commissions and fees increased by EUR 14 million to EUR 17 million (3). Impairment loss on receivables decreased by EUR 32 million to EUR 11 million (42). Operating expenses totalled EUR 94 million (91). The loan portfolio grew by 2% year on year, to EUR 27.3 billion (26.7). The deposit portfolio decreased by 16% to EUR 12.4 billion (14.8). The Corporate Banking and Capital Markets segment’s operating profit increased to EUR 33 million...

Company Announcement No 08/20233 May 2023 Sydbank’s Interim Report – Q1 2023 Historically high income – a strong start to the year Q1 2023 – highlightsProfit for the period of DKK 734m equals a return on equity of 22.1% p.a. after tax Core income of DKK 1,635m is 36% higher compared to the same period in 2022 Trading income of DKK 117m is 17% higher compared to the same period in 2022 Costs (core earnings) of DKK 797m against DKK 799m in the same period in 2022 Core earnings before impairment of DKK 955m are 91% higher compared to the same period in 2022 Impairment charges for loans and advances etc represent an income of DKK 10m Bank loans and advances have risen by DKK 1.2bn, equal to an increase of 2% compared to year-end 2022 The CET1 ratio stands at 18.2%, equal to an increase of 0.9pp compared to year-end 2022CEO Karen Frøsig...

Company announcement no. 28 Net profit of DKK 557 million and return on equity of 19.5% The financial statements for the first quarter of 2023 show a highly satisfactory net profit of DKK 557 million and a return on equity of 19.5%. The Bank’s core income was lifted by strong growth in net interest income driven by rising policy and market rates and the implementation of interest rate changes on the Bank’s deposit and loan products. Business volume growth and buoyant financial markets also contribute favourably to the overall financial performance. On the other hand, the Bank recorded lower net fee income in Q1 2023 due to a lower level of activity in house sales and mortgage credit facilitation as well as in securities trading and asset management. Towards the end of Q1 2023, the collapse and subsequent rescue of two US banks and Switzerland-based...

Stellantis Reports 14% Increase in Q1 2023 Net Revenues,All Segments Contributing PositivelyNet revenues of €47.2 billion, up 14% compared to Q1 2022 mainly due to higher shipments and strong net pricing Consolidated shipments(1) of 1,476 thousand units, up 7% primarily due to improvement in semiconductor order fulfillment versus Q1 2022 Total new vehicle inventory of 1,302 thousand units at March 31, 2023, reflecting a return to normal inventory levels; includes Company inventory of 384 thousand units Ordinary dividend of €1.34 per share approved at AGM to be paid to shareholders on May 4, 2023 €1.5 billion stock buyback initiated, first €500 million tranche expected to be completed in June 2023 Global BEV sales increased 22% versus Q1 2022; ongoing global focus with 9 new BEVs launching in 2023“Stellantis is off to a solid start...

Focus on executing the strategic plan and delivering shareholder value MDG1015 pre-clinical data underline potential in solid tumor therapy Subsequent to Q1, expansion of tools and technologies in our end-to-end technology platform Guidance confirmed; cash runway maintained through Q4 2024Martinsried/Munich, May 3, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2023. The full Quarterly Statement Q1 2023 can be downloaded here: https://medigene.com/investors-media/reports-presentations/ “Since the beginning of 2023, we have been making significant progress on our strategy in addressing the unmet needs in treating solid tumors. We have expanded the...

Financial highlightsBrand registers its fourth consecutive quarter of resilient growth despite the macroeconomic challenges. Q1 2023 organic growth at 1% and like-for-like (LFL) at 0%. LFL in key markets in Europe sequentially improves to 0%, US remains at -7% as in Q4 and Rest of Pandora remains strong at 12%. Network expansion drives 3% growth and generates strong margins. Gross margins continue the upward trend witnessed over past years and reach 77.5%, +1.5pp vs. Q1 2022.  Pricing actions, channel mix and commodity tailwinds contribute positively. As expected, EBIT margin at 21.5% down 1.5pp vs. Q1 2022 reflecting a.o. revenue and cost phasing. Full-year EBIT margin to be broadly in line with last year. Leverage remains low with NIBD/EBITDA at 1.2x. DKK 1.5 billion of share buyback program completed. Assuming no material macroeconomic...

In Q1 2023 Inbank earned a consolidated net profit of 1.9 million euros decreasing 37% year-on-year. The return on equity was 7.3%.Inbank’s loan and subscription portfolio increased by 26% compared to Q1 2022 reaching 856 million euros. The deposit portfolio grew 27% and reached 857 million euros by the end of Q1. At the end of Q1 2023, Inbank’s total assets stood at 1.05 billion euros. Gross merchandise value (GMV) during the first quarter was 155 million euros, which is 14% more than a year ago. GMV through our merchant solutions grew by 15% reaching 68 million. The strongest growth was recorded by our car finance business, where GMV grew 65% to 32 million euros. Subscriptio solutions also showed strong annual growth of 29%, reaching 13 million euros, while direct lending GMV grew 20% and reached 21 million. Because of higher interest...